Recommendations for good clinical practice for DPD bone scintigraphy for cardiac amyloidosis
Nucl Med Commun
.
2024 Apr 1;45(4):253-262.
doi: 10.1097/MNM.0000000000001796.
Epub 2024 Jan 26.
Authors
Kshama Wechalekar
1
,
David Hutt
2
,
Ann Marie Quigley
3
,
Carol Whelan
2
,
Pei San Chan
3
,
Lucy Hossen
1
,
Ian Armstrong
4
,
Parthiban Arumugam
4
,
William Moody
5
,
Ashutosh D Wechalekar
2
Affiliations
1
Department of Nuclear Medicine, Royal Brompton and Harefield Hospitals, London. Part of Guy's and St. Thomas' Foundation Trust, .
2
National Amyloidosis Centre, University College London, .
3
Nuclear Medicine, Royal Free Hospital, London, .
4
Nuclear Medicine Centre, Manchester University NHS Foundation Trust, Manchester and .
5
Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
PMID:
38275011
PMCID:
PMC10916748
DOI:
10.1097/MNM.0000000000001796
No abstract available
MeSH terms
Amyloidosis* / diagnostic imaging
Cardiomyopathies* / diagnostic imaging
Humans
Organotechnetium Compounds
Radionuclide Imaging
Substances
Organotechnetium Compounds